- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-WNT7A
WNT7A Polyclonal Antibody for WB, IF/ICC, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IHC, IF/ICC, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 10605-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | tissu rénal de souris, tissu hépatique de souris |
Résultats positifs en IP | tissu rénal de souris, |
Résultats positifs en IF/ICC | cellules HepG2, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:500-1:2000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 1 publications below |
WB | See 8 publications below |
IHC | See 5 publications below |
IF | See 2 publications below |
Informations sur le produit
10605-1-AP cible WNT7A dans les applications de WB, IHC, IF/ICC, IP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
Réactivité | Humain, rat, souris |
Réactivité citée | rat, Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | WNT7A Protéine recombinante Ag0874 |
Nom complet | wingless-type MMTV integration site family, member 7A |
Masse moléculaire calculée | 39 kDa |
Poids moléculaire observé | 30-39 kDa |
Numéro d’acquisition GenBank | BC008811 |
Symbole du gène | WNT7A |
Identification du gène (NCBI) | 7476 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
The Wnt gene family encodes secreted signaling molecules that bind to frizzled receptors and influence oncogenesis and developmental processes, including regulation of cell fate and patterning during embryogenesis. Wnt7a is normally expressed in several organs, including the lung, testis, lymph node, and brain. As an oncogenic autocrine glycoprotein, Wnt7a promotes tumor invasion and distant metastasis with cancer-associated fibroblasts. Wnt7b is required for endothelial cells derived from pluripotent stem cells to acquire blood-brain barrier properties and may play an important role in the development of myopia in humans. This antibody can both recognize WNT7A and WNT7B.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for WNT7A antibody 10605-1-AP | Download protocol |
IF protocol for WNT7A antibody 10605-1-AP | Download protocol |
IP protocol for WNT7A antibody 10605-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Front Oncol The Role of miR-640: A Potential Suppressor in Breast Cancer via Wnt7b/β-catenin Signaling Pathway. | ||
Oncol Rep Wnt7a predicts poor prognosis, and contributes to growth and metastasis in tongue squamous cell carcinoma.
| ||
Behav Brain Res OGDHL ameliorates cognitive impairment and Alzheimer's disease-like pathology via activating Wnt/β-catenin signaling in Alzheimer's disease mice. | ||
Oncol Rep RNA-binding motif protein 5 negatively regulates the activity of Wnt/β-catenin signaling in cigarette smoke-induced alveolar epithelial injury. | ||
Neurol Res Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice. | ||
NAR Cancer EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer. |